Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Ophthalmology Retina
Published October 23, 2026
Longitudinal analysis of structural biomarkers for disease progression in intermediate age-relate...
October 24, 2026
Medspoke
Medspoke
JAMA Oncology
Published October 22, 2026
00:00
--:--
Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized ...
October 24, 2026
Share
Rilvegostomig Plus Trastuzumab-Deruxtecan for Early-Stage Breast Cancer: The I-SPY2.2 Randomized Clinical Trial.
https://www.medspoke.co/channel_journal?id=795&tap_id=16192
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Annals of Oncology
Published October 23, 2026
Overall survival with adjuvant ribociclib plus nonsteroidal aromatase inhibitor in patients with ...
October 24, 2026
Why are you reporting this TALK?
